[Cabozantinib (hepatocellular carcinoma) - Second Addendum to Commission A18-85]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003548
German
Original Title:
Cabozantinib (hepatozellulaeres Karzinom) - 2. Addendum zum Auftrag A18-85
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g19-11.html
Year Published:
2019
URL for published report:
https://www.iqwig.de/download/G19-11_Cabozantinib_Addendum-zum-Auftrag-A18-85_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Anilides
- Pyridines
- Antineoplastic Agents
- Protein Kinase Inhibitors
Keywords
- Cabozantinib
- Carcinoma ? Hepatocellular
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.